• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种使用机器学习技术对肝内胆管癌表型进行的新分类:一项国际多机构分析。

A Novel Classification of Intrahepatic Cholangiocarcinoma Phenotypes Using Machine Learning Techniques: An International Multi-Institutional Analysis.

机构信息

Department of Surgery, Division of Surgical Oncology, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, OH, USA.

Department of Surgery, University of Verona, Verona, Italy.

出版信息

Ann Surg Oncol. 2020 Dec;27(13):5224-5232. doi: 10.1245/s10434-020-08696-z. Epub 2020 Jun 3.

DOI:10.1245/s10434-020-08696-z
PMID:32495285
Abstract

INTRODUCTION

Patients with intrahepatic cholangiocarcinoma (ICC) generally have a poor prognosis, yet there can be heterogeneity in the patterns of presentation and associated outcomes. We sought to identify clusters of ICC patients based on preoperative characteristics that may have distinct outcomes based on differing patterns of presentation.

METHODS

Patients undergoing curative-intent resection of ICC between 2000 and 2017 were identified using a multi-institutional database. A cluster analysis was performed based on preoperative variables to identify distinct patterns of presentation. A classification tree was built to prospectively assign patients into cluster assignments.

RESULTS

Among 826 patients with ICC, three distinct presentation patterns were noted. Specifically, Cluster 1 (common ICC, 58.9%) consisted of individuals who had a small-size ICC (median 4.6 cm) and median carbohydrate antigen (CA) 19-9 and neutrophil-to-lymphocyte ratio (NLR) levels of 40.3 UI/mL and 2.6, respectively; Cluster 2 (proliferative ICC, 34.9%) consisted of patients who had larger-size tumors (median 9.0 cm), higher CA19-9 levels (median 72.0 UI/mL), and similar NLR (median 2.7); Cluster 3 (inflammatory ICC, 6.2%) comprised of patients with a medium-size ICC (median 6.2 cm), the lowest range of CA19-9 (median 26.2 UI/mL), yet the highest NLR (median 13.5) (all p < 0.05). Median OS worsened incrementally among the three different clusters {Cluster 1 vs. 2 vs. 3; 60.4 months (95% confidence interval [CI] 43.0-77.8) vs. 27.2 months (95% CI 19.9-34.4) vs. 13.3 months (95% CI 7.2-19.3); p < 0.001}. The classification tree used to assign patients into different clusters had an excellent agreement with actual cluster assignment (κ = 0.93, 95% CI 0.90-0.96).

CONCLUSION

Machine learning analysis identified three distinct prognostic clusters based solely on preoperative characteristics among patients with ICC. Characterizing preoperative patient heterogeneity with machine learning tools can help physicians with preoperative selection and risk stratification of patients with ICC.

摘要

介绍

肝内胆管癌(ICC)患者预后一般较差,但临床表现和相关结局可能存在异质性。我们试图根据术前特征识别 ICC 患者的聚类,这些特征可能基于不同的表现模式而具有不同的结局。

方法

使用多机构数据库确定 2000 年至 2017 年间接受根治性切除术治疗的 ICC 患者。根据术前变量进行聚类分析,以确定不同的表现模式。建立分类树,前瞻性地将患者分配到聚类中。

结果

在 826 名 ICC 患者中,观察到三种不同的表现模式。具体而言,第 1 组(常见 ICC,58.9%)由肿瘤较小(中位直径 4.6cm)、CA19-9 中位值为 40.3UI/mL 和中性粒细胞与淋巴细胞比值(NLR)中位值为 2.6 的个体组成;第 2 组(增殖性 ICC,34.9%)由肿瘤较大(中位直径 9.0cm)、CA19-9 中位值较高(72.0UI/mL)、NLR 中位值相似(2.7)的患者组成;第 3 组(炎症性 ICC,6.2%)由肿瘤中等大小(中位直径 6.2cm)、CA19-9 中位数最低(26.2UI/mL)、NLR 中位数最高(13.5)的患者组成(均 P<0.05)。三组患者的中位 OS 逐渐恶化,第 1 组优于第 2 组优于第 3 组{第 1 组 vs. 第 2 组 vs. 第 3 组;60.4 个月(95%置信区间 [CI] 43.0-77.8)vs. 27.2 个月(95% CI 19.9-34.4)vs. 13.3 个月(95% CI 7.2-19.3);P<0.001}。用于将患者分配到不同聚类的分类树与实际聚类分配具有极好的一致性(κ=0.93,95%CI 0.90-0.96)。

结论

机器学习分析仅根据 ICC 患者的术前特征确定了三个不同的预后聚类。使用机器学习工具对术前患者异质性进行特征描述可以帮助医生对 ICC 患者进行术前选择和风险分层。

相似文献

1
A Novel Classification of Intrahepatic Cholangiocarcinoma Phenotypes Using Machine Learning Techniques: An International Multi-Institutional Analysis.一种使用机器学习技术对肝内胆管癌表型进行的新分类:一项国际多机构分析。
Ann Surg Oncol. 2020 Dec;27(13):5224-5232. doi: 10.1245/s10434-020-08696-z. Epub 2020 Jun 3.
2
Long-Term Recurrence-Free and Overall Survival Differ Based on Common, Proliferative, and Inflammatory Subtypes After Resection of Intrahepatic Cholangiocarcinoma.肝内胆管癌切除术后,常见、增殖和炎症亚型与长期无复发生存和总生存的差异。
Ann Surg Oncol. 2023 Mar;30(3):1392-1403. doi: 10.1245/s10434-022-12795-4. Epub 2022 Nov 16.
3
A Machine-Based Approach to Preoperatively Identify Patients with the Most and Least Benefit Associated with Resection for Intrahepatic Cholangiocarcinoma: An International Multi-institutional Analysis of 1146 Patients.一种基于机器的方法,用于术前识别与肝内胆管癌切除相关获益最多和获益最少的患者:来自 1146 例患者的国际多机构分析。
Ann Surg Oncol. 2020 Apr;27(4):1110-1119. doi: 10.1245/s10434-019-08067-3. Epub 2019 Nov 14.
4
Development and Validation of a Laboratory Risk Score (LabScore) to Predict Outcomes after Resection for Intrahepatic Cholangiocarcinoma.实验室风险评分(LabScore)的建立与验证:用于预测肝内胆管细胞癌切除术后的结局。
J Am Coll Surg. 2020 Apr;230(4):381-391.e2. doi: 10.1016/j.jamcollsurg.2019.12.025. Epub 2020 Jan 31.
5
Discordance in prediction of prognosis among patients with intrahepatic cholangiocarcinoma: A preoperative vs postoperative perspective.肝内胆管细胞癌患者预后预测的不一致性:术前与术后视角。
J Surg Oncol. 2019 Nov;120(6):946-955. doi: 10.1002/jso.25671. Epub 2019 Aug 13.
6
Impact of body mass index on tumor recurrence among patients undergoing curative-intent resection of intrahepatic cholangiocarcinoma- a multi-institutional international analysis.体重指数对接受肝内胆管癌根治性切除术患者肿瘤复发的影响-多机构国际分析。
Eur J Surg Oncol. 2019 Jun;45(6):1084-1091. doi: 10.1016/j.ejso.2019.03.004. Epub 2019 Mar 7.
7
The Impact of Preoperative CA19-9 and CEA on Outcomes of Patients with Intrahepatic Cholangiocarcinoma.术前 CA19-9 和 CEA 对肝内胆管细胞癌患者结局的影响。
Ann Surg Oncol. 2020 Aug;27(8):2888-2901. doi: 10.1245/s10434-020-08350-8. Epub 2020 Mar 20.
8
Recurrence Patterns and Timing Courses Following Curative-Intent Resection for Intrahepatic Cholangiocarcinoma.根治性切除术后肝内胆管细胞癌的复发模式和时间进程。
Ann Surg Oncol. 2019 Aug;26(8):2549-2557. doi: 10.1245/s10434-019-07353-4. Epub 2019 Apr 24.
9
Prognostic Utility of the Glasgow Prognostic Score for the Long-Term Outcomes After Liver Resection for Intrahepatic Cholangiocarcinoma: A Multi-institutional Study.《Glasgow 预后评分对肝内胆管细胞癌肝切除术后长期预后的预测价值:一项多中心研究》
World J Surg. 2021 Jan;45(1):279-290. doi: 10.1007/s00268-020-05797-4. Epub 2020 Sep 28.
10
Treatment and Prognosis for Patients With Intrahepatic Cholangiocarcinoma: Systematic Review and Meta-analysis.肝内胆管细胞癌患者的治疗与预后:系统评价和荟萃分析。
JAMA Surg. 2014 Jun;149(6):565-74. doi: 10.1001/jamasurg.2013.5137.

引用本文的文献

1
Comparison of spatial prediction models from Machine Learning of cholangiocarcinoma incidence in Thailand.泰国胆管癌发病率机器学习空间预测模型的比较
BMC Public Health. 2025 Jun 7;25(1):2137. doi: 10.1186/s12889-025-23119-y.
2
Diagnosis of Cholangiocarcinoma: The New Biological and Technological Horizons.胆管癌的诊断:新的生物学与技术前沿
Diagnostics (Basel). 2025 Apr 16;15(8):1011. doi: 10.3390/diagnostics15081011.
3
Application of preoperative NLR-based prognostic model in predicting prognosis of intrahepatic cholangiocarcinoma following radical surgery.

本文引用的文献

1
Prognostic utility of albumin-bilirubin grade for short- and long-term outcomes following hepatic resection for intrahepatic cholangiocarcinoma: A multi-institutional analysis of 706 patients.白蛋白-胆红素分级对肝内胆管癌肝切除术后短期和长期预后的预测价值:706例患者的多机构分析
J Surg Oncol. 2019 Aug;120(2):206-213. doi: 10.1002/jso.25486. Epub 2019 Apr 25.
术前基于中性粒细胞与淋巴细胞比值的预后模型在预测肝内胆管癌根治术后预后中的应用。
Front Nutr. 2024 Oct 30;11:1492358. doi: 10.3389/fnut.2024.1492358. eCollection 2024.
4
Application of AI on cholangiocarcinoma.人工智能在胆管癌中的应用。
Front Oncol. 2024 Jan 29;14:1324222. doi: 10.3389/fonc.2024.1324222. eCollection 2024.
5
Surgical Management of Intrahepatic Cholangiocarcinoma: Quo Vadis.肝内胆管癌的外科治疗:何去何从。
Cancers (Basel). 2023 Sep 23;15(19):4691. doi: 10.3390/cancers15194691.
6
Machine-Based Learning Hierarchical Cluster Analysis: Sex-Based Differences in Prognosis Following Resection of Hepatocellular Carcinoma.基于机器的学习层次聚类分析:肝癌切除术后预后的性别差异。
World J Surg. 2023 Dec;47(12):3319-3327. doi: 10.1007/s00268-023-07194-z. Epub 2023 Sep 30.
7
Efficacy and safety comparison of neoadjuvant chemotherapy followed by surgery and upfront surgery for treating intrahepatic cholangiocarcinoma: a systematic review and meta-analysis.新辅助化疗后手术与直接手术治疗肝内胆管细胞癌的疗效和安全性比较:系统评价和荟萃分析。
BMC Gastroenterol. 2023 Apr 12;23(1):122. doi: 10.1186/s12876-023-02754-y.
8
The Application of Artificial Intelligence to Investigate Long-Term Outcomes and Assess Optimal Margin Width in Hepatectomy for Intrahepatic Cholangiocarcinoma.人工智能在肝内胆管癌肝切除术中调查长期结果和评估最佳切缘宽度的应用。
Ann Surg Oncol. 2023 Jul;30(7):4292-4301. doi: 10.1245/s10434-023-13349-y. Epub 2023 Mar 23.
9
Preoperative neutrophil-to-lymphocyte ratio is prognostic for early recurrence after curative intrahepatic cholangiocarcinoma resection.术前中性粒细胞与淋巴细胞比值对肝内胆管癌根治性切除术后早期复发具有预后价值。
Ann Hepatobiliary Pancreat Surg. 2023 May 31;27(2):158-165. doi: 10.14701/ahbps.22-114. Epub 2023 Feb 20.
10
Artificial intelligence and cholangiocarcinoma: Updates and prospects.人工智能与胆管癌:最新进展与前景
World J Clin Oncol. 2022 Feb 24;13(2):125-134. doi: 10.5306/wjco.v13.i2.125.